« Celebrex Ads Return Despite Continuing Heart Risk Controversy | Main | Antibiotic Tequin Should Be Banned By FDA, Says Public Citizen Petition »

Bristol-Myers Squibb To Stop Selling Antibiotic Drug Tequin

BMS Action Follows Reports Of Serious Blood-Sugar Problems And Recent Warning Label Changes

An April 27, 2006 article by Peter Loftus for Dow Jones Newswires broke the news that Bristol-Myers Squibb Co. has decided to stop selling Tequin (gatifloxacin), an antibiotic that has been associated with potentially fatal blood-sugar problems.

As background, in mid-February 2006 Bristol-Myers Squibb (BMS), the FDA, and Health Canada announced that the package insert, or label, for Tequin would be changed to include stronger warnings about the threat of life-threatening events from blood-sugar changes.  The February 2006 label change also recommended that Tequin not be taken by diabetics, who must carefully control blood-sugar levels to avoid complications.

On March 1, 2006 the New England Journal of Medicine (NEJM) published online an early-release version of an editorial and an article alerting doctor about serious blood-sugar problems associated with Tequin. Specifically, the study reported in this March 2006 NEJM article found that patients using Tequin had four times the risk of hypoglycemia (low blood sugar) and a remarkable 17 times the risk of hyperglycemia (high blood sugar) when compared to other antibiotics.  These types of changes in blood sugar can induce coma and other serious medical problems, including death. 

Tequin was used to treat lung, sinus, skin, or urinary-tract infections, as well as certain sexually transmitted diseases. Tequin was approved by the FDA in 1999.

(Posted by: Tom Lamb)

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/t/trackback/369531/4758396

Listed below are links to weblogs that reference Bristol-Myers Squibb To Stop Selling Antibiotic Drug Tequin :

Comments

dear sir or madam

now what will FDA will do. either withdraw from international market or it will recalled . secondally Teva has also got tntative approval from FDA . waht will Teva will do now . will the product Gatifloxacin will be available in future or not . these are the questions in the mind of doctors and consumers. i think FDA medwatch has immediatelt respond to this publics safety issue. thanks . aaziz rizvi pakistan

Post a comment

Comments are moderated, and will not appear on this weblog until the author has approved them.

My Photo

RSS Feed

  • FeedBurner

Email Delivery

Let Us Know


Sponsored By

Case Review

Featured On

Bookmarking

  • Add to Technorati Favorites
AddThis Social Bookmark Button

Poll: Federal Preemption -- Good or Bad Policy?

Resources

  • Drug Interaction Checker
    Program alerts patients to some drug-drug interaction possibilities when taking two or more prescription drugs.
  • FDA MedWatch
    MedWatch is the U.S. FDA site for safety information on prescription drugs and other medical products.
  • Health Canada MedEffect
    Health Canada's MedEffect site provides drug product safety announcements and other information for patients.
  • Medication Errors Reporting Program (MERP)
    Submit a confidential report to national voluntary program.
  • NIH MedlinePlus
    MedlinePlus will direct you to information that will help answer health questions.
  • Patient Medical Records Copying Cost Statutes
    State statutes that control what amount can be charged when patient requests their own medical records in U.S.
  • PDRhealth.com
    Based on most trusted database of prescription drug information, Physicians’ Desk Reference.
  • PharmedOut
    Intended to help prescribers identify and counter inappropriate pharmaceutical promotion practices.

Sites to See

Search Engine

  • Google

    WWW
    www.drug-injury.com

Affiliations

  • BlogBurst.com

Blog Archives

Common Feed

  • FeedBurner

Custom Feeds

  • Add Drug Injury Watch to Newsburst from CNET News.com

  • Add to My AOL

  • Subscribe in NewsGator Online

  • Add to Google

  • Subscribe in Bloglines

HitTail.com

Disclaimer


  • DRUG INJURY WATCH is for general information purposes only, and should not be regarded as medical advice or legal advice.... (For more, please see the About page.)

See You Again